TRPC6 Inhibitor BI 764198 in Focal Segmental Glomerulosclerosis: Phase 2 Study Design
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-12-01
|
| Series: | Kidney International Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S246802492301519X |
| _version_ | 1797404582836436992 |
|---|---|
| author | Howard Trachtman Matthias Kretzler Hailey E. Desmond Wansuk Choi Raymond C. Manuel Nima Soleymanlou |
| author_facet | Howard Trachtman Matthias Kretzler Hailey E. Desmond Wansuk Choi Raymond C. Manuel Nima Soleymanlou |
| author_sort | Howard Trachtman |
| collection | DOAJ |
| first_indexed | 2024-03-09T02:57:06Z |
| format | Article |
| id | doaj.art-7d2ce554e6144d519f8547492ad6b5f7 |
| institution | Directory Open Access Journal |
| issn | 2468-0249 |
| language | English |
| last_indexed | 2024-03-09T02:57:06Z |
| publishDate | 2023-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj.art-7d2ce554e6144d519f8547492ad6b5f72023-12-05T04:15:34ZengElsevierKidney International Reports2468-02492023-12-0181228222825TRPC6 Inhibitor BI 764198 in Focal Segmental Glomerulosclerosis: Phase 2 Study DesignHoward Trachtman0Matthias Kretzler1Hailey E. Desmond2Wansuk Choi3Raymond C. Manuel4Nima Soleymanlou5Division of Nephrology, University of Michigan, Ann Arbor, Michigan, USADivision of Nephrology, University of Michigan, Ann Arbor, Michigan, USADivision of Nephrology, University of Michigan, Ann Arbor, Michigan, USABoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USABoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USABoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA; Correspondence: Nima Soleymanlou, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, USA.http://www.sciencedirect.com/science/article/pii/S246802492301519Xfocal segmental glomerulosclerosisphase 2 clinical trialpodocytesproteinuriaresearch designTRPC6 cation channel |
| spellingShingle | Howard Trachtman Matthias Kretzler Hailey E. Desmond Wansuk Choi Raymond C. Manuel Nima Soleymanlou TRPC6 Inhibitor BI 764198 in Focal Segmental Glomerulosclerosis: Phase 2 Study Design Kidney International Reports focal segmental glomerulosclerosis phase 2 clinical trial podocytes proteinuria research design TRPC6 cation channel |
| title | TRPC6 Inhibitor BI 764198 in Focal Segmental Glomerulosclerosis: Phase 2 Study Design |
| title_full | TRPC6 Inhibitor BI 764198 in Focal Segmental Glomerulosclerosis: Phase 2 Study Design |
| title_fullStr | TRPC6 Inhibitor BI 764198 in Focal Segmental Glomerulosclerosis: Phase 2 Study Design |
| title_full_unstemmed | TRPC6 Inhibitor BI 764198 in Focal Segmental Glomerulosclerosis: Phase 2 Study Design |
| title_short | TRPC6 Inhibitor BI 764198 in Focal Segmental Glomerulosclerosis: Phase 2 Study Design |
| title_sort | trpc6 inhibitor bi 764198 in focal segmental glomerulosclerosis phase 2 study design |
| topic | focal segmental glomerulosclerosis phase 2 clinical trial podocytes proteinuria research design TRPC6 cation channel |
| url | http://www.sciencedirect.com/science/article/pii/S246802492301519X |
| work_keys_str_mv | AT howardtrachtman trpc6inhibitorbi764198infocalsegmentalglomerulosclerosisphase2studydesign AT matthiaskretzler trpc6inhibitorbi764198infocalsegmentalglomerulosclerosisphase2studydesign AT haileyedesmond trpc6inhibitorbi764198infocalsegmentalglomerulosclerosisphase2studydesign AT wansukchoi trpc6inhibitorbi764198infocalsegmentalglomerulosclerosisphase2studydesign AT raymondcmanuel trpc6inhibitorbi764198infocalsegmentalglomerulosclerosisphase2studydesign AT nimasoleymanlou trpc6inhibitorbi764198infocalsegmentalglomerulosclerosisphase2studydesign |